Integra LifeSciences Corporation

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Integra LifeSciences Corporation sits in the top decile of US sponsors by registered trial count (#336 of 15,742 sponsors by registered trial count).

60 total trials 3 currently recruiting 38 completed later-stage tilt top decile by trial count

Integra LifeSciences Corporation: 60 sponsored US clinical trials, 3 recruiting.

Integra LifeSciences Corporation sponsors 60 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 38 completed. 5 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Diabetic Foot Ulcer, with 2 trials.

Top-decile sponsor footprint

Integra LifeSciences Corporation ranks in the top decile of sponsors by registered trial count (#336 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 6/100

38 of 57 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (66.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

60 total, page 1 of 2

RECRUITING

AERA Pediatrics Registry

NCT07071298
RECRUITING NA

A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers

NCT06453187
RECRUITING

The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation

NCT04494295
COMPLETED NA

MicroMatrix® Flex in Tunneling Wounds

NCT06629506
COMPLETED

Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study

NCT06297187
COMPLETED

T-GENVIH-003 LTFU (Long Term Follow Up) Study

NCT06034652
COMPLETED

Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair

NCT05610267
TERMINATED

REINVENT Registry (Registry of the Nerve Gap Repair From Integra)

NCT05339594
TERMINATED NA

NeuraGen 3D Pilot Study

NCT05343143
COMPLETED NA

The Purpose of This Study is to Determine Whether CerebroFlo™ EVD Catheter is Effective During the Treatment of Intraventricular Hemorrhage (IVH)

NCT05113381
COMPLETED

Suturable DuraGen™ PMCF Study

NCT04923867
TERMINATED NA

Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of Care

NCT03626623
COMPLETED

Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF)

NCT03816202
TERMINATED

The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series

NCT04041037
TERMINATED

Cytal® Wound Matrix and MicroMatrix® Wound Study

NCT03632954
COMPLETED NA

AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers

NCT03547635
COMPLETED NA

Comparing Concomitant Use of ACell MicroMatrix® and ACell Cytal™ to Standard of Care in Stage 3 or 4 Pressure Injuries

NCT03283787
COMPLETED NA

PriMatrix for the Management of Diabetic Foot Ulcers

NCT03010319
TERMINATED Phase 3

Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use

NCT01840085
TERMINATED NA

MEDIHONEY® Gel Versus Collagenase for Wound Debridement

NCT02482948
TERMINATED

Global Sinus Surgery Registry

NCT02347943
COMPLETED NA

Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers

NCT02209051
COMPLETED NA

ACell MatriStem Pelvic Floor Matrix Versus Native Tissue Repair, Comparative Study

NCT02021279
COMPLETED NA

Study of Safety and Efficacy for the Eustachian Tube Balloon Catheter

NCT02087150
COMPLETED

Retrospective Study Evaluating Outcomes for Integra® Skin Sheet Products in Lower Extremity Complex Wounds

NCT01947387
TERMINATED NA

A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers

NCT01858545
TERMINATED Phase 3

Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers

NCT01849965
TERMINATED Phase 3

Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers

NCT01830348
COMPLETED NA

Comparison of Balloon Sinuplasty In-Office Versus Medical Management for Recurrent Acute Sinusitis Patients (CABERNET)

NCT01714687
COMPLETED

Medical Therapy Versus Balloon Sinus Dilation for Patients With Chronic Rhinosinusitis

NCT01685229
TERMINATED NA

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix

NCT01729286
COMPLETED

Earset Healthy Volunteer Study

NCT01611246
COMPLETED NA

Tympanostomy Tube Placement in Children in the Office (Inova Study)

NCT01496287
COMPLETED NA

inVENT-visIOn Study

NCT01444391
COMPLETED

DuraSeal Exact Spine Sealant System Post-Approval Study

NCT01410864
COMPLETED

Healthy Volunteer Study

NCT01346332
COMPLETED NA

inVENT-In-Office Study

NCT01324271
TERMINATED NA

A Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers

NCT01270633
COMPLETED Phase 2

Evaluation of the Tympanostomy Tube Delivery System

NCT01202578
COMPLETED

A Multicenter, Prospective, Observational Study With PriMatrix for the Treatment of Neuropathic Diabetic Foot Ulcers

NCT01228526
COMPLETED

Optimization and Refinement of Technique in In-Office Sinus Dilation 2

NCT01107379
COMPLETED NA

A Safety and Efficacy Study of INTEGRA® Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers

NCT01060670
COMPLETED NA

Acclarent Tympanostomy Tube Delivery System for the Treatment of Patients Requiring Tympanostomy Tube Insertion

NCT02150044
TERMINATED NA

An Evaluation of SprayShield in Reducing Post-Operative Adhesion Formation Following Major Open Abdominal Surgery

NCT01002287
COMPLETED NA

Anesthetizing the Tympanic Membrane in Healthy Volunteers

NCT01047904
COMPLETED

Large Abdominal Hernia Repair With SurgiMend 3.0

NCT00892333
COMPLETED NA

Clinical Study of the Tympanostomy Tube Delivery System

NCT00939796
COMPLETED NA

Clinical Study of Safety and Efficacy for the Relieva Stratus With Elution of Triamcinolone Acetonide

NCT00791934
TERMINATED Phase 3

PleuraSeal Pivotal Study (US)

NCT00748124
COMPLETED NA

Balloon Sinus Dilation In Office or OR

NCT00939393
Page 1 of 2 Next →

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 4
Phase 4 1

Therapeutic Areas

Diabetic Foot Ulcer 2
Recurrent Acute Rhinosinusitis 1
Cerebrospinal Fluid Leakage, Subdural 1
Dural Sealing 1
Evaluate Performance and Reliability of Iontophoresis System 1
Condylomata Acuminata 1
Vulvar Intraepithelial Neoplasia 1
Chronic Sinusitis 1
Supratentorial Hemorrhage 1
Sinusitis 1

Where Integra LifeSciences Corporation enrollment is open (later-stage tilt)

3 recruiting of 60 indexed (5% open); 38 completed (63%).

Phase mix: 5 late (III/IV) vs 1 early (I/II) (later-stage heavy).

Top condition: Diabetic Foot Ulcer (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Integra LifeSciences Corporation: open-pipeline peers nationwide

Peers matched on 60 registered trials and 5% open enrollment, not the therapeutic-area sidebar.

Integra LifeSciences Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 10203040506070 0%5%10%15%20%25% Total trials Recruiting share Integra LifeSciences CorporationHenry M. Jackson Foundation for the Advancement of Military MedicineEndo USA Inc., a Keenova Therapeutics CompanyNICHD Neonatal Research NetworkClinical Nutrition Research Center, Illinois Institute of TechnologyAvera McKennan Hospital & University Health CenterHonorHealth Research InstituteLumenis BeNathan Kline Institute for Psychiatric Research
Integra LifeSciences Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Integra LifeSciences Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 60 trials (± recruiting share)

Sponsors near 5% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Integra LifeSciences Corporation page

60 registered trials is a research-attention snapshot, not an endorsement of Integra LifeSciences Corporation or any single study.

  • 3 of Integra LifeSciences Corporation's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Diabetic Foot Ulcer is the condition Integra LifeSciences Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Diabetic Foot Ulcer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Integra LifeSciences Corporation pipeline card: 60 registered trials from official public datasets.Report a data error.